Novadip Biosciences raised €28M in a Series A round in Sep 2015. The company is based in Ottignies-Louvain-la-Neuve, Belgium. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €28M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
